Baker IDI Study – help research novel therapies for the treatment of Type 2 Diabetes! 10 December 2014 What is the study about? Baker IDI Heart and Diabetes Institute is currently investigating the effects of new medicines and developmental compounds on fat and sugar metabolism. These compounds may lead to new future treatments for type 2 diabetes. This project also aims to understand the mechanisms behind development and progression of type 2 diabetes. Who can take part? Males Aged 35-65 years Overweight Individuals with pre-diabetes, or type 2 diabetes, or healthy Currently not taking any medication Non-smokers or Ex-smokers What’s involved? Visit 1 (3 hours) Comprehensive medical check by a cardiologist Oral glucose tolerance test Electrocardiogram (ECG) Visit 2 (2 hours) Muscle and Fat biopsies The biopsies are a simple procedure conducted under local anaesthetic. Further Information Interested persons should contact Melissa Formosa on (03) 9076 6518 or [email protected] This research has been approved by the Alfred Hospital Ethics Committee.
Media releases 13 May 2026 Momentum builds following government response to diabetes inquiry The diabetes sector has welcomed the Federal Government’s response to the Parliamentary Inquiry into Diabetes, which provides in-principle support for... Continue Reading
Media releases 9 May 2026 Research reveals genes may determine who benefits most from popular weight-loss and diabetes medicines New research supported by Diabetes Australia has confirmed that a person’s genes can influence how well widely used diabetes medicines... Continue Reading
Blog 3 May 2026 Diabetes and Alzheimer’s: separating fact from fiction While research shows that type 2 diabetes is associated with a higher risk of Alzheimer's, many people with diabetes never develop dementia, and Alzheimer’s disease also affects people without diabetes. Continue Reading
